Profile
Priyanka Shah is currently working as the VP of Investor Relations & Communications at Kinnate Biopharma, Inc. Previously, she worked as the Head of Media Relations at Mirati Therapeutics, Inc.
Priyanka Shah active positions
| Companies | Position | Start |
|---|---|---|
| KINNATE BIOPHARMA INC. | Investor Relations Contact | - |
Former positions of Priyanka Shah
| Companies | Position | End |
|---|---|---|
| MIRATI THERAPEUTICS | Public Communications Contact | 2022-03-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Priyanka Shah